Hans‐Peter Holthoff
Impact in
- Internal Medicine top 10%
- Venous Thromboembolism Diagnosis and Management
- Hematology top 10%
- Platelet Disorders and Treatments
Papers in
-
- Thyroid Disorders and Treatments 7
- Growth Hormone and Insulin-like Growth Factors 3
- Co-authors
- Martin UngererGötz MünchZhongmin LiMeinrad GawazAndreas ReimannMartin J. LohseKerstin UhlandDieter E. Jenne
- Journals
- PLoS ONE (5 papers)Endocrinology (2 papers)Circulation Research (2 papers)Cells (2 papers)Analytical and Bioanalytical Chemistry (1 paper)
- Partner nations
- GermanyAustriaUnited States
In The Last Decade
Hans‐Peter Holthoff
24 papers receiving 629 citations
Peers
Comparison fields: 5 of 92
- Internal Medicine 54
- Hematology 111
- Cardiology and Cardiovascular Medicine 200
- Endocrinology, Diabetes and Metabolism 124
- Pathology and Forensic Medicine 125
Countries citing papers authored by Hans‐Peter Holthoff
This map shows the geographic impact of Hans‐Peter Holthoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans‐Peter Holthoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans‐Peter Holthoff more than expected).
Fields of papers citing papers by Hans‐Peter Holthoff
This network shows the impact of papers produced by Hans‐Peter Holthoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans‐Peter Holthoff. The network helps show where Hans‐Peter Holthoff may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hans‐Peter Holthoff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 4 | |
| 4 | 2022 | 4 | |
| 5 | 2022 | 10 | |
| 6 | 2021 | 11 | |
| 7 | 2021 | 3 | |
| 8 | 2021 | 17 | |
| 9 | 2020 | 21 | |
| 10 | 2020 | 2 | |
| 11 | 2019 | 25 | |
| 12 | 2018 | 4 | |
| 13 | 2017 | 27 | |
| 14 | 2016 | 24 | |
| 15 | 2015 | 43 | |
| 16 | 2013 | 58 | |
| 17 | 2013 | 68 | |
| 18 | 2012 | 67 | |
| 19 | 2012 | 42 | |
| 20 | 2011 | 42 |
About Hans‐Peter Holthoff
Hans‐Peter Holthoff is a scholar working on Endocrinology, Diabetes and Metabolism, Hematology, Pathology and Forensic Medicine, Internal Medicine and Cardiology and Cardiovascular Medicine, having authored 26 papers that have together received 676 indexed citations. Recurring topics across this work include Thyroid Disorders and Treatments (7 papers), Ophthalmology and Eye Disorders (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Erythrocyte Function and Pathophysiology (3 papers), Viral Infections and Immunology Research (3 papers), Growth Hormone and Insulin-like Growth Factors (3 papers) and Receptor Mechanisms and Signaling (3 papers). The work is most often cited by research in Internal Medicine (54 citations), Hematology (111 citations), Cardiology and Cardiovascular Medicine (200 citations), Endocrinology, Diabetes and Metabolism (124 citations) and Pathology and Forensic Medicine (125 citations). Hans‐Peter Holthoff has collaborated with scholars based in Germany, Austria and United States. Frequent co-authors include Martin Ungerer, Götz Münch, Zhongmin Li, Meinrad Gawaz, Zhongmin Li, Andreas Reimann, Martin J. Lohse, Kerstin Uhland, Dieter E. Jenne and Stefan Duhr. Their work appears in journals such as PLoS ONE, Endocrinology, Circulation Research, Cells and Analytical and Bioanalytical Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.